A week on from the Bezos Centre for Sustainable Protein 2026 Conference in London, New Food Deputy Editor Ben Cornwell reflects on the ideas, debates and breakthroughs that defined the event and why ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the ...

By Edward Dankwah, GNA Accra, March 11, GNA – The Council for Scientific and Industrial Research – Savanna Agricultural Research Institute (CSIR-SARI) has engaged stakeholders in Ghana’s biotechnology ...

Advances in biotechnology have made it possible to grow meat from animal cells in a laboratory. But what happens if those cells come from a human instead of a cow or chicken? Scientists and ethicists ...

The Food and Drug Administration’s head of vaccines and biotechnology drugs, Dr. Vinay Prasad, is leaving the agency as of ...

A biotechnology spin-out company from The University of Manchester has closed a £3m seed funding round led by Northern Gritstone.

Cytotrait, a biotechnology spin-out company from The University of Manchester focused on the development of novel traits for ...

Cytotrait, a biotechnology spinout from The University of Manchester commercialised with support from the University of Manchester Innovation Factory, focused on the development of novel traits for ...

The 2026 MDA Clinical & Scientific Conference Highlights Breakthroughs in Neuromuscular Research, Innovative Therapies, and ...

Talent is the primary resource for comprehensive rural revitalization. Reforming education and training systems is therefore essential to nurturing professionals who understand agriculture and are ...

Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.

Pharmaceutical companies in India are driving innovation, biosimilars, APIs & global exports while strengthening research, manufacturing & healthcare access.